Hypertension Diagnosis and Initial Treatment

Diagnostic Thresholds

The American College of Cardiology recommends diagnosing hypertension when blood pressure is ≥130/80 mmHg, confirmed ideally with ambulatory monitoring or home measurements 1
Patients with blood pressure ≥160/100 mmHg require immediate pharmacological treatment, regardless of other risk factors 2, 3
Patients with blood pressure 140-159/90-99 mmHg require treatment if there is target organ damage, established cardiovascular disease, diabetes, or a 10-year cardiovascular risk ≥20% 2, 4

The American Heart Association recommends implementing lifestyle modifications in all hypertensive patients before or simultaneously with pharmacological therapy, including weight loss, a DASH or Mediterranean diet, sodium restriction, potassium increase, physical activity, moderate alcohol consumption, and smoking cessation 1, 5

For blood pressure 130-150/80-90 mmHg, initiate with a single anti-hypertensive agent 1, 3
For blood pressure ≥150/90 mmHg or ≥160/100 mmHg, initiate with two anti-hypertensive agents simultaneously to achieve more effective control 1, 3
First-line agents include ACE inhibitors, ARBs, thiazide diuretics, or dihydropyridine calcium channel blockers 3, 1

In patients with diabetes, use ACE inhibitors or ARBs as first-line therapy, and consider adding a diuretic or calcium channel blocker if necessary 3, 5
In patients with established coronary artery disease, use ACE inhibitors or ARBs as first-line therapy, and consider adding a beta-blocker if there is a history of myocardial infarction, angina, or heart failure with reduced ejection fraction 6, 3

The general target blood pressure is <130/80 mmHg for most adults 1, 5
The target blood pressure for patients with diabetes, kidney disease, or established cardiovascular disease is <130/80 mmHg 3, 5
For adults ≥65 years, the target systolic blood pressure is <130 mmHg if well-tolerated 1

Evaluate serum creatinine and potassium 7-14 days after initiating ACE inhibitors, ARBs, or diuretics, and adjust medications or add additional agents if necessary 1
Monitor for hypokalemia with diuretics and hyperkalemia with ACE inhibitors/ARBs, and avoid using these agents in pregnant or breastfeeding women 1, 3

Approximately 20-30% of hypertensive patients achieve blood pressure targets (<140/90 mmHg) with a single antihypertensive medication, except in grade 1 hypertension where the percentage may be slightly higher, according to the European Society of Cardiology 7
The response rate (reduction of systolic/diastolic blood pressure of 20/10 mmHg) with any agent in monotherapy is approximately 50%, but this does not equate to achieving therapeutic targets, as stated by the European Society of Cardiology 7

In 15-20% of hypertensive patients, a combination of three medications is needed to achieve blood pressure control, with the most rational combination being a renin-angiotensin system blocker, a calcium antagonist, and a diuretic in effective doses, as recommended by the European Society of Cardiology 8
The additional reduction in blood pressure when combining medications from two different classes is approximately five times greater than doubling the dose of a single medication, according to the European Society of Cardiology 8

The sequential monotherapy approach is laborious and frustrating for physicians and patients, leading to low adherence and delaying urgent blood pressure control in high-risk hypertensive patients, as noted by the European Society of Cardiology 7
In high-risk patients with very high blood pressure or organ damage, the frustration of seeking effective monotherapies should be avoided, and combination therapy should be initiated directly, as recommended by the European Society of Cardiology 7